Condition |
Distinguishing features |
Guillain-Barré syndromea |
History of recent infection; paresthesias; frequently ascending paralysis; early deep areflexia; in advanced disease elevated CSF protein levels; abnormal EMG results |
Myasthenia gravis |
Recurrent paresis; abnormal EMG results; sustained response to cholinesterase inhibitors |
Stroke |
Frequently asymmetric paresis; CNS abnormalities observed on neuroimaging studies |
Poisoning with substances having neurodepressant effectsb |
History of exposure to toxic agents; high levels of drugs or toxins in body fluids |
Lambert-Eaton syndrome |
Increased muscle strength with prolonged contraction; confirmed small cell lung cancer; EMG results similar to botulism |
CNS infectionsc |
Altered mental status; CNS abnormalities on neuroimaging studies and EEG; abnormal CSF |
CNS tumor |
Frequently asymmetric paresis; CNS abnormalities on neuroimaging studies |
Inflammatory myopathies |
Increased creatine kinase levels |
Complications of diabetes mellitus |
Sensory neuropathy; paresis involving only few cranial nerves |
Hypothyroidism |
Abnormal test results |
a Including variants of Guillain-Barré syndrome, particularly Miller-Fisher syndrome. b For instance, acute ethyl alcohol intoxication, poisoning with organic phosphates, carbon monoxide, nerve gas, magnesium. c Particularly involving the brainstem. | |
CNS, central nervous system; CSF, cerebrospinal fluid; EEG, electroencephalography; EMG, electromyography. |